{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:34:32Z","timestamp":1786368872341,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-04310-7","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:34:12Z","timestamp":1780490052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rosuvastatin calcium administration and its impact on myocardial microcirculation and postoperative recovery in patients undergoing coronary artery bypass grafting"],"prefix":"10.1186","volume":"21","author":[{"given":"Xizheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"2","key":"4310_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.hfc.2025.01.003","volume":"21","author":"PN Patel","year":"2025","unstructured":"Patel PN, Poliner MC, Bossone E, Baliga RR. Coronary Artery Disease and Heart Failure: Medical Management and Future Direction. Heart Fail Clin. 2025;21(2):241\u201356.","journal-title":"Heart Fail Clin"},{"issue":"8","key":"4310_CR2","doi-asserted-by":"publisher","first-page":"101228","DOI":"10.1016\/j.cpcardiol.2022.101228","volume":"48","author":"V Sucato","year":"2023","unstructured":"Sucato V, Coppola G, Manno G, Vadal\u00e0 G, Novo G, Corrado E, et al. Coronary Artery Disease in South Asian Patients: Cardiovascular Risk Factors, Pathogenesis and Treatments. Curr Probl Cardiol. 2023;48(8):101228.","journal-title":"Curr Probl Cardiol"},{"issue":"6","key":"4310_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/HCO.0000000000001172","volume":"39","author":"S Sandner","year":"2024","unstructured":"Sandner S, Florian A, Ruel M. Coronary artery bypass grafting in acute coronary syndromes: modern indications and approaches. Curr Opin Cardiol. 2024;39(6):485\u201390.","journal-title":"Curr Opin Cardiol"},{"issue":"3","key":"4310_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3949\/ccjm.92a.23071","volume":"92","author":"R Ramsingh","year":"2025","unstructured":"Ramsingh R, Bakaeen FG. Coronary artery bypass grafting: Practice trends and projections. Cleve Clin J Med. 2025;92(3):181\u201391.","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"4310_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/HCO.0000000000001090","volume":"38","author":"GM Iacona","year":"2023","unstructured":"Iacona GM, Bakhos JJ, Tong MZ, Bakaeen FG. Coronary artery bypass grafting in left ventricular dysfunction: when and how. Curr Opin Cardiol. 2023;38(6):464\u201370.","journal-title":"Curr Opin Cardiol"},{"issue":"2","key":"4310_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3121\/cmr.2023.1806","volume":"21","author":"SH Rezkalla","year":"2023","unstructured":"Rezkalla SH, Kloner RA. Invasive versus Conservative Management in Coronary Artery Disease. Clin Med Res. 2023;21(2):95\u2013104.","journal-title":"Clin Med Res"},{"issue":"6","key":"4310_CR7","doi-asserted-by":"publisher","first-page":"e012568","DOI":"10.1161\/CIRCINTERVENTIONS.122.012568","volume":"16","author":"NR Smilowitz","year":"2023","unstructured":"Smilowitz NR, Toleva O, Chieffo A, Perera D, Berry C. Coronary Microvascular Disease in Contemporary Clinical Practice. Circulation Cardiovasc interventions. 2023;16(6):e012568.","journal-title":"Circulation Cardiovasc interventions"},{"key":"4310_CR8","doi-asserted-by":"crossref","unstructured":"Ciaramella L, Di Serafino L, Mitrano L, De Rosa ML, Carbone C, Rea FS et al. Invasive Assessment of Coronary Microcirculation: A State-of-the-Art Review. Diagnostics (Basel Switzerland). 2023;14(1):86.","DOI":"10.3390\/diagnostics14010086"},{"issue":"2","key":"4310_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/ejcts\/ezy107","volume":"54","author":"M Hellmann","year":"2018","unstructured":"Hellmann M, Piotrowski J, Anisimowicz L, Cracowski JL. A mystery of the myocardial microcirculation during coronary artery bypass grafting. Eur J cardio-thoracic surgery: official J Eur Association Cardio-thoracic Surg. 2018;54(2):405.","journal-title":"Eur J cardio-thoracic surgery: official J Eur Association Cardio-thoracic Surg"},{"issue":"11","key":"4310_CR10","doi-asserted-by":"publisher","first-page":"e0310696","DOI":"10.1371\/journal.pone.0310696","volume":"19","author":"L Liu","year":"2024","unstructured":"Liu L, Deng Y, Li L, Yang X, Yin Z, Lai Y. Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis. PLoS ONE. 2024;19(11):e0310696.","journal-title":"PLoS ONE"},{"key":"4310_CR11","unstructured":"Bajaj T, Giwa AO, Rosuvastatin. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Al Giwa declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2025. StatPearls Publishing LLC.; 2025."},{"issue":"10","key":"4310_CR12","first-page":"1177","volume":"51","author":"B Liu","year":"2012","unstructured":"Liu B, Zhang JY, Cao HM, Wang Q, Wang HB. Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis. Internal medicine (Tokyo. Japan). 2012;51(10):1177\u201382.","journal-title":"Japan)"},{"issue":"3","key":"4310_CR13","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jtcvs.2014.10.030","volume":"149","author":"S Matsuo","year":"2015","unstructured":"Matsuo S, Saiki Y, Adachi O, Kawamoto S, Fukushige S, Horii A, et al. Single-dose rosuvastatin ameliorates lung ischemia-reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension. J Thorac Cardiovasc Surg. 2015;149(3):902\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"4310_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12967-024-04875-8","volume":"22","author":"JY Ryu","year":"2024","unstructured":"Ryu JY, Jang EH, Lee J, Kim JH, Youn YN. Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validation. J translational Med. 2024;22(1):166.","journal-title":"J translational Med"},{"key":"4310_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4137\/CMC.S4324","volume":"6","author":"A Luvai","year":"2012","unstructured":"Luvai A, Mbagaya W, Hall AS, Barth JH. Rosuvastatin: a review of the pharmacology and clinical effectiveness in cardiovascular disease. Clin Med Insights Cardiol. 2012;6:17\u201333.","journal-title":"Clin Med Insights Cardiol"},{"issue":"3","key":"4310_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.suc.2022.01.005","volume":"102","author":"EF Sulava","year":"2022","unstructured":"Sulava EF, Johnson JC. Management of Coronary Artery Disease. Surg Clin North Am. 2022;102(3):449\u201364.","journal-title":"Surg Clin North Am"},{"key":"4310_CR17","doi-asserted-by":"crossref","unstructured":"Ozguler IM, Burma O, Uysal A, Akbulut H. Rosuvastatin Lowers Systemic Inflammatory Response in Coronary Artery Bypass Graft Accompanied by Cardiopulmonary Bypass Surgery: A Randomized Controlled Study. Clin Invest Med . 2015;38(4):E154\u201363.","DOI":"10.25011\/cim.v38i4.24260"},{"issue":"10","key":"4310_CR18","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/ejhf.2652","volume":"24","author":"JW Ostrominski","year":"2022","unstructured":"Ostrominski JW, Vaduganathan M, Claggett BL, de Boer RA, Desai AS, Dobreanu D, et al. Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. Eur J Heart Fail. 2022;24(10):1892\u2013901.","journal-title":"Eur J Heart Fail"},{"key":"4310_CR19","doi-asserted-by":"crossref","unstructured":"Elhadad ZM, Kassem AB, Amrawy AME, Salahuddin A, El-Bassiouny NA. Comparative Study Between the Effects of High Doses of Rosuvastatin and Atorvastatin on Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction. Cardiovascular drugs and therapy. 2024.","DOI":"10.1007\/s10557-024-07621-w"},{"issue":"1","key":"4310_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3892\/br.2014.366","volume":"3","author":"W Wang","year":"2015","unstructured":"Wang W, Zhang Y, Gao M, Wang J, Hou Y. Effect of rosuvastatin on atrial structural remodeling in rabbits with myocardial infarction. Biomedical Rep. 2015;3(1):78\u201382.","journal-title":"Biomedical Rep"},{"issue":"5","key":"4310_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41569-022-00799-2","volume":"20","author":"M Pesce","year":"2023","unstructured":"Pesce M, Duda GN, Forte G, Girao H, Raya A, Roca-Cusachs P, et al. Cardiac fibroblasts and mechanosensation in heart development, health and disease. Nat reviews Cardiol. 2023;20(5):309\u201324.","journal-title":"Nat reviews Cardiol"},{"key":"4310_CR22","doi-asserted-by":"crossref","unstructured":"Bazgir F, Nau J, Nakhaei-Rad S, Amin E, Wolf MJ, Saucerman JJ et al. The Microenvironment of the Pathogenesis of Cardiac Hypertrophy. Cells. 2023;12(13):1780.","DOI":"10.3390\/cells12131780"},{"key":"4310_CR23","doi-asserted-by":"publisher","first-page":"3863726","DOI":"10.1155\/2016\/3863726","volume":"2016","author":"C Csonka","year":"2016","unstructured":"Csonka C, S\u00e1rk\u00f6zy M, Pipicz M, Dux L, Csont T. Modulation of Hypercholesterolemia-Induced Oxidative\/Nitrative Stress in the Heart. Oxidative Med Cell Longev. 2016;2016:3863726.","journal-title":"Oxidative Med Cell Longev"},{"key":"4310_CR24","doi-asserted-by":"crossref","unstructured":"Somers T, Siddiqi S, Janssen MCM, Morshuis WJ, Maas RGC, Buikema JW, et al. Effect of statins on mitochondrial function and contractile force in human skeletal and cardiac muscle. Volume 180. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie; 2024. p. 117492.","DOI":"10.1016\/j.biopha.2024.117492"},{"issue":"6","key":"4310_CR25","doi-asserted-by":"publisher","first-page":"300060523118254","DOI":"10.1177\/03000605231182547","volume":"51","author":"L Zhou","year":"2023","unstructured":"Zhou L, Hu X, Zhang H, Lu H, Lin Y, Wang W, et al. Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction. J Int Med Res. 2023;51(6):3000605231182547.","journal-title":"J Int Med Res"},{"issue":"1","key":"4310_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41419-021-03389-1","volume":"12","author":"A Chen","year":"2021","unstructured":"Chen A, Chen Z, Zhou Y, Wu Y, Xia Y, Lu D, et al. Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation. Cell Death Dis. 2021;12(1):78.","journal-title":"Cell Death Dis"},{"key":"4310_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1749-8090-5-60","volume":"5","author":"E Ege","year":"2010","unstructured":"Ege E, Dereli Y, Kurban S, Sarig\u00fcl A. Atorvastatin pretreatment diminishes the levels of myocardial ischemia markers early after CABG operation: an observational study. J Cardiothorac Surg. 2010;5:60.","journal-title":"J Cardiothorac Surg"},{"key":"4310_CR28","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.2147\/JIR.S490896","volume":"17","author":"T Chen","year":"2024","unstructured":"Chen T, Zheng J, Bao C, Wang Y, Wang S, Liang L, et al. Guanxinning for Residual Inflammation of Stable Coronary Artery Disease: A Pilot Randomized Controlled Trial. J Inflamm Res. 2024;17:8047\u201360.","journal-title":"J Inflamm Res"},{"issue":"2","key":"4310_CR29","doi-asserted-by":"publisher","first-page":"e13883","DOI":"10.1111\/eci.13883","volume":"53","author":"C Pabst","year":"2023","unstructured":"Pabst C, Schreck N, Benner A, Hegenbart U, Sch\u00f6nland S, Radujkovic A, et al. Statin-based endothelial prophylaxis and outcome after allogeneic stem cell transplantation. Eur J Clin Invest. 2023;53(2):e13883.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"4310_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/jama.286.1.64","volume":"286","author":"MA Albert","year":"2001","unstructured":"Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001;286(1):64\u201370.","journal-title":"JAMA"},{"issue":"1","key":"4310_CR31","first-page":"49","volume":"76","author":"BG de Liyis","year":"2024","unstructured":"de Liyis BG, Jagannatha GNP, Kosasih AM, Darma I, Artha I. Efficacy of single high-dose statin prior to percutaneous coronary intervention in acute coronary syndrome: a systematic review and meta-analysis. Egypt heart journal: (EHJ) : official Bull Egypt Soc Cardiol. 2024;76(1):49.","journal-title":"Egypt heart journal: (EHJ) : official Bull Egypt Soc Cardiol"},{"issue":"11","key":"4310_CR32","first-page":"e11760","volume":"12","author":"S Umrani","year":"2020","unstructured":"Umrani S, Jamshed W, Rizwan A. Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Markers in Acute Coronary Syndrome. Cureus. 2020;12(11):e11760.","journal-title":"Cureus"},{"issue":"12","key":"4310_CR33","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1074\/mcp.M115.054031","volume":"14","author":"SM Gordon","year":"2015","unstructured":"Gordon SM, McKenzie B, Kemeh G, Sampson M, Perl S, Young NS, et al. Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory Properties. Mol Cell proteomics: MCP. 2015;14(12):3247\u201357.","journal-title":"Mol Cell proteomics: MCP"},{"issue":"6","key":"4310_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/00043798-200112000-00008","volume":"8","author":"R Paoletti","year":"2001","unstructured":"Paoletti R, Fahmy M, Mahla G, Mizan J, Southworth H. Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients: a randomized, double-blind study. J Cardiovasc Risk. 2001;8(6):383\u201390.","journal-title":"J Cardiovasc Risk"},{"issue":"6","key":"4310_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1089\/cell.2018.0053","volume":"21","author":"X Wang","year":"2019","unstructured":"Wang X, Chen J, Huang X. Rosuvastatin Attenuates Myocardial Ischemia-Reperfusion Injury via Upregulating miR-17-3p-Mediated Autophagy. Cell reprogramming. 2019;21(6):323\u201330.","journal-title":"Cell reprogramming"},{"issue":"7","key":"4310_CR36","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/clc.21008","volume":"35","author":"N Girerd","year":"2012","unstructured":"Girerd N, Pibarot P, Daleau P, Voisine P, O\u2019Hara G, Despr\u00e9s JP, et al. Statins reduce short- and long-term mortality associated with postoperative atrial fibrillation after coronary artery bypass grafting: impact of postoperative atrial fibrillation and statin therapy on survival. Clin Cardiol. 2012;35(7):430\u20136.","journal-title":"Clin Cardiol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04310-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04310-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04310-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:04:09Z","timestamp":1786367049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04310-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4310"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04310-7","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures in this study adhered to the ethical standards established by the institutional and national human experimentation committees and were in accordance with the Declaration of Helsinki of 1964 and its later amendments. The study received approval from Beijing Tongren Hospital\u2019s Institutional Review Board (IRB) (Approval No. TREC2025-KY149). Given that the data used in the study consisted of anonymized patient information and posed no potential risks or impacts on patient care, Beijing Tongren Hospital\u2019s IRB and ethics committee decided to waive the requirement for informed consent for this retrospective study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"524"}}